FINWIRES · TerminalLIVE
FINWIRES

Gilead Sciences Finalizes $7.8 Billion Acquisition of Arcellx

By

-- Gilead Sciences (GILD) said Tuesday it completed the acquisition of Arcellx in a deal worth $7.8 billion, which paid target investors $115 in cash along with a $5 contingent value right for each share owned.

The contingent payout requires an experimental multiple myeloma therapy to generate at least $6 billion in worldwide net sales through 2029, the company said.

The acquisition grants full ownership of the treatment to eliminate future royalty and milestone obligations, Gilead Sciences said.

The resulting accounting impact is projected to lower 2026 diluted earnings by approximately $5.57 to $5.67 per share, the company added.

Price: $128.82, Change: $+1.07, Percent Change: +0.84%

Related Articles

Australia

Velo3D Closes $50 Million Registered Direct Offering

Velo3D (VELO) said Tuesday it closed an underwritten registered direct offering of nearly 3.6 million common shares for gross proceeds of about $50 million.Net proceeds will be used for working capital and general corporate purposes, the company added.Price: $13.76, Change: $-0.57, Percent Change: -3.98%

$VELO
Australia

First Financial Bankshares Ups Quarterly Dividend 15.8% to $0.22 a Share, Payable July 1 to Holders of Record June 12

Price: $32.61, Change: $+0.18, Percent Change: +0.56%

$FFIN
Mining & Metals

First Atlas Resources Sells MacKenzie East Claims in Quebec to LaFleur Minerals

First Atlas Resources (HHE.CN) on Tuesday said it agreed to sell a 100% interest in its MacKenzie East Claims located in the Val-d'Or gold camp, Quebec, to LaFleur Minerals (LFLR.CN) in a cash and stock deal.LaFleur will buy the property in exchange for $30,000 in cash, and 175,000 shares of LaFleur Minerals. The cash portion is payable within 48 hours of execution of the agreement, the company said.The share consideration will be issued upon receipt of exchange acceptance or, if not required, within five business days following closing of the deal. The property consists of 46 mineral claims covering about 1,781 hectares.The deal allows First Atlas to monetize a non-core asset while retaining exposure to the upside of the Val-d'Or region through its equity interest in LaFleur, it added.Shares of First Atlas were last seen down $0.005 to $0.10 on the Canadian Securities Exchange.

$HHE.CN$LFLR.CN